On May 2, 2023, the Board of Directors of the Cyclo Therapeutics, Inc. appointed William Conkling to serve as director of the Company pursuant to the Purchase Agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | +2.19% | -4.76% | -11.95% |
05-01 | HC Wainwright Starts Cyclo Therapeutics With Buy Rating, $3 Price Target | MT |
03-18 | Cyclo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.95% | 40.2M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- CYTH Stock
- News Cyclo Therapeutics, Inc.
- Cyclo Therapeutics, Inc. Appoints William Conkling to Serve as Director